AUDACIOUS Opens a Medical Cannabis Clinic in Southeast Asia, Expanding its Global Presence in the Thai Medical Cannabis Market


AUDACIOUS is the first US multi-state operator to open a cannabis clinic in Thailand In partnership with the Thai company Golden Triangle Health.

LA VEGAS, March 21, 2022 /PRNewswire/ – As Thailand’s vibrant medical cannabis market begins to blossom, BOLD and partner based in Thailand Health Golden Triangle have partnered to open the first Herbidus Medical Center in bangkokwhich is also the first medical cannabis clinic in South East Asia supported by a US Multistate Carrier (MSO).

BOLD Logo (CNW Group/Australis Capital Inc.)

Herbidus is among the first clinics of Asia who can prescribe cannabis for medical treatment in accordance with the law. It uses drugs approved by the Government Pharmaceutical Organization and is staffed by physicians who adhere to global standards for the use of cannabis in the treatment of patients.

“Interest in medical cannabis is growing rapidly in Thailand,” noted Terry Booth, CEO of AUDACIOUS. “With the opening of Herbidus Medical Center, we look forward to bringing AUDACIOUS’ cannabis expertise and seasoned business leadership to the Thai cannabis market. This is one of many initiatives that we undertake with Golden Triangle Health, which together with its parent company enjoys strong distribution channels through Thailandas well as nimble and powerful white labeling capabilities for manufacturing cannabis products.”

Mr. Booth continued, “GTH will also receive support from our Scientific Director, Dr. Jason Dick, and will be able to put his knowledge and experience to good use. This gives Herbidus access to one of the world’s leading medical cannabis science, allowing Herbidus patients to benefit from the highest standards of care in the industry. This will take advantage of the years of research we have done in Canada and other countries, including Dr. Dyck’s studies of one of the world’s largest databases of medical cannabis users to identify the main reasons for the authorization of medical cannabis and the health outcomes of these patients.

As Thailand begins to more aggressively expand opportunities for legal cannabis businesses, AUDACIOUS and Golden Triangle Health are poised to serve the nation of 70 million people with cannabis services and products built on years of successful lawsuits and cannabis professionals in North America.

Itself a spin-off of Thai public company NR Instant Produce PCL with a market capitalization close to $400 million, GTH is well positioned to grow rapidly in the nascent Thai market. After a soft launch, Herbidus has already seen nearly 800 patients, showing pent-up demand in Thailand for services related to medical cannabis. dr. Jason DickCSO at AUDACIOUS, commented: “Leveraging insights gained from years of studying one of the world’s largest databases of medical cannabis users, we have made significant progress in understanding medical conditions for which patients seek treatment with cannabis as well as in the study of the health outcomes of these patients.The results of these studies will now form an integral part of the knowledge base of practitioners at our Herbidus clinics to help our patients .

Golden Triangle co-founder Tom Kruesopon said, “Golden Triangle Health already has strong brand equity in Thailand and through Asia. Our partnership with AUDACIOUS to open Herbidus helps propel us even further,” “We believe that together we can be one of the most significant players in the Asian cannabis market, following our joint launch in the Asian market CBD earlier this year.”

Added AUDACIOUS COO Duke Fu“We believe that the nascent cannabis market in Asia offers a new and massive addressable market for AUDACIOUS. Given Golden Triangle Health’s extensive and positive track record in cannabis and hemp distribution, manufacturing, and healthcare in Thailandwe know this partnership is ideal for showcasing the true medical and economic benefits of cannabis.”

About Audacity
AUDACIOUS is a next-gen MSO building tomorrow’s cannabis industry from the ground up, led by an industry pioneer Terry Booth and an accomplished management team with a proven track record in the industry. With operations that range from industry-leading sustainable cultivation design and optimization to retail storefronts, in-house flower growing and manufacturing for award-winning brands, AUDACIOUS offers products and solutions for everyone. Expanding rapidly through innovative partnerships and collaborations, AUDACIOUS is forging the inclusive cannabis community of tomorrow today. Learn more about AUDACIOUS here.

AUDACIOUS common stock trades on the CSE under the symbol “AUSA” and on the OTCQB under the symbol “AUSAF”.

Terry Booth
Terry Booth
Chief Executive Officer

Neither the Canadian Securities Exchange nor its regulation services provider accepts responsibility for the adequacy or accuracy of this press release.

Caution Regarding Forward-Looking Statements: This press release contains certain statements and information that may constitute “forward-looking information” within the meaning of applicable Canadian securities laws. All statements in this press release, other than statements of historical facts, including statements regarding future estimates, plans, goals, timing, assumptions or expectations of future performance, are forward-looking statements and contain forward-looking information. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “would”. Forward-looking statements are based on certain material assumptions and analyzes made by the Company and on the opinions and estimates of management as of the date of this press release. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or information. Although the Company’s management has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking statements or information, there may be other factors that cause the results are not those anticipated, estimated or intended. . There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on this information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statements, forward-looking information or financial outlook incorporated by reference herein, except as required by applicable securities laws.



View original content to download multimedia: -cannabis-market-301506449.html

SOURCE Australis Capital Inc.


Comments are closed.